Who has invested in Cyted?

EQT Life Sciences are named among the investors backing Cyted.

Cyted Funding: $44M Raised, Series B (2025)

Cyted funding overview

Cyted is based in Cambridge, United Kingdom. Cyted has raised $44M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2025. The round record for Cyted runs through 2025; nothing later has been disclosed. Investors on record include EQT Life Sciences.

Cyted at a glance

Total raised: $44M
Latest round: Series B
Latest round date: August 2025
Headquarters: Cambridge, United Kingdom
Notable investors: EQT Life Sciences

Frequently asked about Cyted funding

How much has Cyted raised?: Cyted has raised $44M in total disclosed funding across the rounds on record.
Who has invested in Cyted?: EQT Life Sciences are named among the investors backing Cyted.
What was the latest Cyted funding round?: The most recent disclosed round is a Series B, announced in August 2025.
Where is Cyted based?: Cyted is based in Cambridge, United Kingdom.
When did Cyted last raise?: The last disclosed Cyted round closed in August 2025 at Series B.

Cyted totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.

Cyted Funding: $44M Raised, Series B (2025)

Cyted funding overview

Cyted at a glance

Frequently asked about Cyted funding

Companies related to Cyted (36)

Browse related funding lists (6)